2026-05-07
38%
External coverage
ENGN
enGene TherapeuticsBNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
Curated Events
0
Active
Recent Headlines
8
New
Recent news sentiment
-0.3
30-day score
Company
-
30-day
Macro
-
30-day
Pulse
-
30-day
Curated events
No material screener or newswire events are stored for this ticker yet.
Sentiment decomposition
-0.3
30-day score
Company-55%
Macro-30%
Pulse-15%
The 30-day sentiment score is a decayed blend of Company, Macro, and Pulse components.
Recent headlines
Headline
Time
Relevance
2026-03-09
38%
External coverage
2026-02-27
0%
External coverage
2026-02-12
23%
External coverage
2026-02-04
38%
External coverage
2025-12-22
38%
External coverage
enGenes Detalimogene Selected for FDA Manufacturing Pilot Program to Support Manufacturing Readiness
2025-12-02
38%
External coverage
2025-09-11
38%
External coverage
As of 2026-05-07 • Updated scheduledSource: News desk